canrenoic acid has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arena, U; Ascione, A; Bernardi, M; Bolondi, L; Donati, G; Ferraù, O; Gatta, A; Gentilini, P; Mazzanti, R; Piscaglia, F; Sacerdoti, D; Salerno, F; Trevisani, F; Visentin, S | 1 |
| Aveta, P; Menozzi, A; Modena, MG; Rossi, R | 1 |
2 trial(s) available for canrenoic acid and Disease Exacerbation
| Article | Year |
|---|---|
Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis.
Topics: Aged; Ascites; Canrenoic Acid; Disease Progression; Double-Blind Method; Esophageal and Gastric Varices; Female; Humans; Incidence; Kidney Function Tests; Liver Cirrhosis; Male; Middle Aged; Mineralocorticoid Receptor Antagonists | 2006 |
Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction.
Topics: Canrenoic Acid; Collagen; Disease Progression; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardial Infarction | 2001 |